Insider sales are immaterial in size relative to market cap and consistent with post-earnings liquidity diversification. The CSO's exercise-and-sell pattern is mechanical (not informational). The President's $1.9M sale is notable in absolute terms but still under 0.01% of market cap. No follow-through action warranted, monitor for larger sales or an unusual increase in selling frequency.
INCY drugs
INCY drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 5 $119.80entry
- T+1 · 3mo ago −1.19%α −1.03% · $118.38
- T+5 · 3mo ago +0.81%α +0.46% · $120.77
- T+20 · 3mo ago +7.54%α +8.14% · $128.83
- T+60 · 19d ago −2.50%α −2.45% · $116.80
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The CSO and President of R&D at Incyte sold a combined $2.16M in open-market shares in the week following the Q2 2026 earnings release. The CSO's sales were part of a planned exercise-and-sell pattern (option exercises paired with same-day sales), while the President's $1.9M sale was a single large open-market disposition. The total open-market sales represent ~0.009% of the $24B market cap, trivial in proportional terms.
Key Financial Metrics
Key Facts
- President Pablo J. Cagnoni sold 15,902 shares at ~$119.70 for ~$1.90M on 2026-07-31
- CSO Patrick A. Mayes sold 2,167 shares at ~$119.47 for ~$261K on 2026-07-31
- Mayes also engaged in multiple option exercises and same-day sales on 2026-07-31 and 2026-08-03, totaling ~$4.4M in combined sales across both dates, all paired with derivative exercises, consistent with a pre-planned liquidity/vesting pattern
- Total open-market sales of ~$2.16M represent ~0.009% of Incyte's $24B market cap
- The cluster follows Incyte's Q2 2026 beat-and-raise earnings (EPS $2.81 vs $2.15 consensus, revenue $1.67B vs $1.49B), which included a one-time CMS settlement benefit
- The cluster is strongly C-suite (President of R&D and CSO) but the sales are small in proportional terms and the CSO's trades follow a mechanical exercise-and-sell pattern
Financial Impact
Total open-market sales of ~$2.16M, representing ~0.009% of Incyte's $24B market cap. Negligible proportional impact.
Risk Factors
- If additional C-suite sales emerge in the next 30 days, the cluster could signal broader insider distribution
- The Q2 beat included a $246M one-time CMS benefit, if ex-item revenue trends soften, selling could accelerate
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-INCY-1785902420714 |
Track record
18 reports on INCY
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +23.70% at T+60 after the Jun 8, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $118.50 Now $120.97 +2.08% settles Feb 16
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $123.09 Now $120.97 −1.72% settles Feb 12
- Nov 13, 20263d ago 8-K Neutral 3/10 Entry $119.45 Now $120.97 +1.27% settles Feb 12
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $120.97 Now $120.97 +0.00% settles Feb 11
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $122.27 Now $120.97 −1.06% settles Feb 9
- Nov 6, 202610d ago 144 Neutral 4/10 Entry $121.89 Now $120.97 −0.75% settles Feb 5
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $122.85 Now $120.97 −1.53% settles Feb 2
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $116.80 Now $120.97 +3.57% settles Jan 27
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $115.71 Now $120.97 +4.55% settles Jan 21
- Aug 14, 202613w ago Insider Cluster Bearish 4/10 Entry $123.50 to $120.30 Now $120.97 +2.05% ▲ +2.59% −0.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers